Department of Psychiatry, Cerrahpaşa School of Medicine, Istanbul University, 34303, Kocamustafapaşa-Fatih/Istanbul, Turkey.
Department of Endocrinology and Metabolism, Cerrahpaşa School of Medicine, Istanbul University, 34303, Kocamustafapaşa-Fatih/Istanbul, Turkey.
Arch Sex Behav. 2018 Nov;47(8):2349-2361. doi: 10.1007/s10508-018-1189-4. Epub 2018 Mar 28.
Body dissatisfaction plays an important role in the development of psychiatric problems such as eating disorders as well as gender dysphoria (GD). Cross-sex hormonal treatment (CHT) alleviates the dissatisfaction by making various changes in the body. We examined the alteration of body uneasiness, eating attitudes and behaviors, and psychological symptoms longitudinally in Turkish participants with female-to-male gender dysphoria (FtM GD) after CHT. Thirty-seven participants with FtM GD and 40 female controls were asked to complete the Body Uneasiness Test to explore different areas of body-related psychopathology, the Eating Attitudes Test to assess eating disturbances, and the Symptom Checklist-90 Revised to measure psychological state, both before CHT and after 6 months of CHT administration. The baseline mean body weight, BMI scores, body uneasiness scores, and general psychopathological symptoms of participants with FtM GD were significantly higher than female controls, whereas baseline eating attitudes and behaviors were not significantly different. Over time, FtM GD participants' mean body weight and BMI scores increased, body uneasiness and general psychopathological symptoms decreased, and eating attitudes and behaviors had not changed at 24th weeks following CHT administration compared to baseline. CHT may have a positive impact on body uneasiness and general psychopathological symptoms in participants with FtM GD. However, CHT does not have an impact on eating attitudes and behaviors.
身体不满在精神障碍的发展中起着重要作用，例如饮食障碍和性别焦虑症（GD）。跨性别激素治疗（CHT）通过使身体发生各种变化来减轻这种不满。我们在 CHT 后对土耳其女性到男性性别焦虑症（FtM GD）患者进行了纵向研究，以检查身体不适，饮食态度和行为以及心理症状的改变。要求 37 名患有 FtM GD 的参与者和 40 名女性对照者完成身体不适测试，以探索与身体相关的精神病理学的不同领域，饮食态度测试以评估饮食障碍，症状清单 90 修订版以衡量心理状态，这些都是在 CHT 之前和 CHT 治疗 6 个月后进行的。FtM GD 参与者的基线平均体重，BMI 评分，身体不适评分和一般心理病理症状均明显高于女性对照组，而基线饮食态度和行为则无明显差异。随着时间的流逝，FtM GD 参与者的平均体重和 BMI 评分增加，身体不适和一般心理病理症状减少，而与基线相比，在 CHT 治疗后 24 周时，饮食态度和行为没有变化。CHT 可能对 FtM GD 患者的身体不适和一般心理病理症状有积极影响。但是，CHT 对饮食态度和行为没有影响。
